MOLECULE HOLDINGS (ERV2) — Working Capital to Net Assets Ratio
MOLECULE HOLDINGS (ERV2) has a Working Capital to Net Assets ratio of 168.8% as of October 2022. Working capital of €-6.24 Million (current assets of €1.28 Million minus current liabilities of €7.52 Million) is measured against net assets of €-3.69 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See ERV2 net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
MOLECULE HOLDINGS Working Capital to Net Assets (2021–2022)
This chart shows how MOLECULE HOLDINGS's Working Capital to Net Assets ratio has evolved across 2 annual periods from 2021 to 2022. As of October 2022, the ratio stands at 168.8%, reflecting working capital of €-6.24 Million against net assets of €-3.69 Million EUR. Check tangible equity quality of MOLECULE HOLDINGS to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for MOLECULE HOLDINGS (2021–2022)
The table below presents the year-by-year Working Capital to Net Assets ratio for MOLECULE HOLDINGS from 2021 to 2022, covering 2 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of MOLECULE HOLDINGS.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 168.8% | €-6.24 Million | €-3.69 Million | €1.28 Million | €7.52 Million | ▲ +426.9 pp |
| 2021 | -258.1% | €-1.65 Million | €638.39K | €2.71 Million | €4.35 Million | — |